(Q37293624)

19 August 2017

1 reference

title

Metabolic remodelling of the failing heart: beneficial or detrimental? (English)

1 reference

19 August 2017

Marc van Bilsen

1

1 reference

PubMed ID

18854380

19 August 2017

Frans A van Nieuwenhoven

series ordinal

2

1 reference

PubMed ID

18854380

19 August 2017

Ger J van der Vusse

series ordinal

3

1 reference

19 August 2017

14 October 2008

1 reference

19 August 2017

Cardiovascular Research

1 reference

19 August 2017

81

1 reference

19 August 2017

3

1 reference

19 August 2017

420-428

1 reference

Energy metabolism in heart failure

19 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Myocardial substrate metabolism in the normal and failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Is the failing heart energy starved? On using chemical energy to support cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

The failing heart--an engine out of fuel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Influence of substrate supply on cardiac efficiency, as measured by pressure-volume analysis in ex vivo mouse hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Abnormal mitochondrial respiration in failed human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Cardiac fatty acid metabolism is preserved in the compensated hypertrophic rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

NHE-1 inhibition improves impaired mitochondrial permeability transition and respiratory function during postinfarction remodelling in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Differential changes in respiratory capacity and ischemia tolerance of isolated mitochondria from atrophied and hypertrophied hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Increased mitochondrial uncoupling proteins, respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Oxidative capacity in failing hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Uncoupling proteins in human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Total-body and myocardial substrate oxidation in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Free fatty acid kinetics and oxidation in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Myocardial perfusion reserve and oxidative metabolism contribute to exercise capacity in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Compensated cardiac hypertrophy is characterised by a decline in palmitate oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Pyruvate dehydrogenase and the regulation of glucose oxidation in hypertrophied rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Transient activation of p38 MAP kinase and up-regulation of Pim-1 kinase in cardiac hypertrophy despite no activation of AMPK

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Nuclear receptor signaling and cardiac energetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Cardiac PPARalpha expression in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Metabolic cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Forkhead transcription factors coordinate expression of myocardial KATP channel subunits and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Very-long-chain acyl-coenzyme a dehydrogenase deficiency in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Cytosolic energy reserves determine the effect of glycolytic sugar phosphates on sarcoplasmic reticulum Ca2+ release in cat ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

The regulation of ion channels and transporters by glycolytically derived ATP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Effects of chronic activation of peroxisome proliferator-activated receptor-alpha or high-fat feeding in a rat infarct model of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPARalpha and PPARdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Trimetazidine normalizes postischemic function of hypertrophied rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

Decreased Myocardial Free Fatty Acid Uptake in Patients With Idiopathic Dilated Cardiomyopathy: Evidence of Relationship With Insulin Resistance and Left Ventricular Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN282

21 January 2018

Identifiers

DOI

10.1093/CVR/CVN282

1 reference

19 August 2017

1 reference

PubMed ID

18854380